Docusate sodium salt
SIAL/86140 - purum, ≥96.0% (TLC)
Synonym: AOT; Bis(2-ethylhexyl) sulfosuccinate sodium salt; Sodium bis(2-ethylhexyl) sulfosuccinate; Sulfobutanedioic acid bis(2-ethylhexyl ester) sodium salt; Sulfosuccinic acid bis(2-ethylhexyl) ester sodium salt; ‘Dioctyl’ sulfosuccinate sodium salt
CAS Number: 577-11-7
Empirical Formula (Hill Notation): C20H37NaO7S
Molecular Weight: 444.56
EC Number: 209-406-4
MDL Number: MFCD00012455
Linear Formula: C20H37NaO7S
Product Type: Chemical
| assay | ≥96.0% (TLC) |
| form | solid |
| functional group | ester |
| sulfonic acid | |
| grade | purum |
| impurities | ≤2% water |
| InChI | 1S/C20H38O7S.Na/c1-5-9-11 |
| InChI key | APSBXTVYXVQYAB-UHFFFAOYSA |
| Quality Level | 200  |
| SMILES string | [Na+].CCCCC(CC)COC(=O)CC( |
| Application: | Docusate sodium salt can be used as a surfactant in the synthesis of magnetic nanoparticles by co-precipitation method. |
| Application: | Forms reverse micelles in hydrocarbon solvents; Suitable for the solubilization of the major myelin transmembrane proteolipid |
| General description: | Docusate sodium salt is an emollient which can combine with the active pharmaceutical ingredients (APIs) such as ranitidine hydrochloride and lidocaine hydrochloride to form hydrophobic ionic liquids (IL-APIs)). |
| Symbol |  GHS05 |
| Signal word | Danger |
| Hazard statements | H315 - H318 |
| Precautionary statements | P264 - P280 - P302 + P352 - P305 + P351 + P338 - P332 + P313 - P362 + P364 |
| Hazard Codes | Xi |
| Risk Statements | 38-41 |
| Safety Statements | 26-39 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 2 |
| Purity | ≥96.0% (TLC) |
| UNSPSC | 12352100 |